ROLE OF TNF AND IL-1 IN INFECTIONS WITH TOXOPLASMA-GONDII
Authors:
- GE GRAUGGGE GRAU
- JC PECHEREJPJC PECHERE
- 1 January 1990
- journal article
- research article
- Vol. 69 (1) , 33-37
Abstract
Mice lethally infected with the C56 strain of Toxoplasma gondii and treated with purified recombinant murine tumour necrosis factor (TNF, 1 .mu.g/day/mouse for 8 days), recombinant human interleukin-1 (IL-1.alpha. or IL-1.beta., 100 ng/day/mouse for 5 days) or a single dose of a combination of TNF (1 .mu.g/mouse) and IL-1.alpha. or IL-1.beta. (100 ng/mouse) were significantly protected against death (P < 0.05-0.001 as compared with untreated infected controls). Mice infected with 100,000 tachyzoites of the highly virulent RH strain of T. gondii released serum TNF in relation to the time after infection and were primed to secrete an enhanced level of serum TNF upon stimulation with bacterial lipopolysaccharide (LPS). In vitro studies showed that interferon-gamma (IFN-.gamma.) increased the antimicrobial activity of murine peritoneal macrophages whereas TNF, IL-1.alpha. and IL-1.beta. did not. TNF, however, synergized with the anti-toxoplasmic effect provided by IFN-.gamma. and this activity was blocked by anti-TNF antibodies. IFN-.gamma. induced the production of TNF and the anti-toxoplasmic effect provided by IFN-.gamma. seemed to be dependent partly on the production of TNF. We conclude that TNF and IL-1 may play a significant role in modulating the host''s immune defense against T. gondii infection.Keywords
This publication has 24 references indexed in Scilit:
- Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.The Journal of Immunology, 1988
- A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.Proceedings of the National Academy of Sciences, 1988
- Production of tumor necrosis factor during murine listeriosis.The Journal of Immunology, 1987
- Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.The Journal of Immunology, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Strain Differences of Interferon–Generating Capacity and Resistance in Toxoplasma–Infected MiceMicrobiology and Immunology, 1986
- Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.Journal of Experimental Medicine, 1986
- Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi.The Journal of Immunology, 1986
- An investigation of the antigenic structure of Toxoplasma gondiiParasite Immunology, 1981
- Purification and physico-chemical characterization of rabbit tumor necrosis factor.The Journal of Immunology, 1980